In addition to cytokines, our results align with the previous in vivo and clinical findings that reported the upregulated levels of chemokines such as Eotaxin, MIP-1α and MIP-1β during IBD [130,131]. This evidence concerns the gene CCL3 and inflammatory bowel disease.